Filtered By:
Source: Netherlands Heart Journal
Condition: Diabetes
Countries: Netherlands Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a  10-year follow-up study.
CONCLUSION: The majority of recently diagnosed healthy AF patients develop cardiovascular diseases with a consequent change in thromboembolic risk profile within a short time frame. A comprehensive follow-up of this patient category is necessary to avoid over- and undertreatment with anticoagulants. PMID: 30953281 [PubMed - as supplied by publisher]
Source: Netherlands Heart Journal - April 4, 2019 Category: Cardiology Authors: Weijs B, Dudink EAMP, de Vos CB, Limantoro I, Tieleman RG, Pisters R, Cheriex EC, Luermans JGLM, Crijns HJGM Tags: Neth Heart J Source Type: research

Red blood cell transfusion in patients with ST-elevation myocardial infarction-a  meta-analysis of more than 21,000 patients.
CONCLUSIONS: Red blood cell transfusion increases the morbidity and mortality in patients with STEMI. This difference could not be explained by the higher morbidity in the red blood cell transfusion group alone. Further randomised controlled trials are required to provide a reliable haemoglobin threshold for these patients. PMID: 30039381 [PubMed - as supplied by publisher]
Source: Netherlands Heart Journal - July 23, 2018 Category: Cardiology Authors: Mincu RI, Rassaf T, Totzeck M Tags: Neth Heart J Source Type: research

Stroke risk in patients with device-detected atrial high-rate episodes.
Abstract Cardiovascular implantable electronic devices (CIEDs) can detect atrial arrhythmias, i. e. atrial high-rate episodes (AHRE). The thrombo-embolic risk in patients showing AHRE appears to be lower than in patients with clinical atrial fibrillation (AF) and it is unclear whether the former will benefit from oral anticoagulants. Based on currently available evidence, it seems reasonable to consider antithrombotic therapy in patients without documented AF showing AHRE >24 hours and a CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years [doubled], diabetes mellitus, prior stroke [...
Source: Netherlands Heart Journal - October 20, 2017 Category: Cardiology Authors: Erküner Ö, Rienstra M, Van Gelder IC, Schotten U, Crijns HJGM, Luermans JGLM Tags: Neth Heart J Source Type: research